Lipopolysaccharides (LPS) is increased in non-alcoholic fatty liver disease (NAFLD), but its relationship with liver inflammation is not defined. We studied Escherichia Coli-LPS in patients with biopsy-proven NAFLD, 25 simple steatosis (NAFL), and 25 non-alcoholic steatohepatitis (NASH), and in mice with diet-induced NASH. NASH patients had higher serum LPS and hepatocytes LPS localization than controls, which was correlated with serum zonulin and pNF-κB expression. Toll-like receptor 4 positive (TLR4+ ) macrophages were higher in NASH than NAFL or controls and correlated with serum LPS. NASH biopsies showed a higher CD61+ platelets, and most of them were TLR4+ . TLR4+ platelets correlated with serum LPS values. In mice with NASH, LPS serum levels and LPS hepatocyte localization were increased compared to control mice and associated with NF-κB activation. Mice on aspirin developed lower fibrosis and extent compared to untreated ones. Treatment with TLR4 inhibitor resulted in lower liver inflammation in mice with NASH. Conclusion: In NAFLD, Escherichia Coli-LPS may increase liver damage by inducing macrophage and platelet activation through the TLR4 pathway.

Increased liver localization of lipopolysaccharides in human and experimental non-alcoholic fatty liver disease / Carpino, Guido; Del Ben, Maria; Pastori, Daniele; Carnevale, Roberto; Baratta, Francesco; Overi, Diletta; Francis, Heather; Cardinale, Vincenzo; Onori, Paolo; Safarikia, Samira; Cammisotto, Vittoria; Alvaro, Domenico; Svegliati-Baroni, Gianluca; Angelico, Francesco; Gaudio, Eugenio; Violi, Francesco. - In: HEPATOLOGY. - ISSN 0270-9139. - (2019). [10.1002/hep.31056]

Increased liver localization of lipopolysaccharides in human and experimental non-alcoholic fatty liver disease

Svegliati-Baroni, Gianluca;
2019-01-01

Abstract

Lipopolysaccharides (LPS) is increased in non-alcoholic fatty liver disease (NAFLD), but its relationship with liver inflammation is not defined. We studied Escherichia Coli-LPS in patients with biopsy-proven NAFLD, 25 simple steatosis (NAFL), and 25 non-alcoholic steatohepatitis (NASH), and in mice with diet-induced NASH. NASH patients had higher serum LPS and hepatocytes LPS localization than controls, which was correlated with serum zonulin and pNF-κB expression. Toll-like receptor 4 positive (TLR4+ ) macrophages were higher in NASH than NAFL or controls and correlated with serum LPS. NASH biopsies showed a higher CD61+ platelets, and most of them were TLR4+ . TLR4+ platelets correlated with serum LPS values. In mice with NASH, LPS serum levels and LPS hepatocyte localization were increased compared to control mice and associated with NF-κB activation. Mice on aspirin developed lower fibrosis and extent compared to untreated ones. Treatment with TLR4 inhibitor resulted in lower liver inflammation in mice with NASH. Conclusion: In NAFLD, Escherichia Coli-LPS may increase liver damage by inducing macrophage and platelet activation through the TLR4 pathway.
2019
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11566/276989
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 108
  • Scopus 238
  • ???jsp.display-item.citation.isi??? 225
social impact